医院手术量对翻修全膝关节置换术后再翻修的影响
该研究基于苏格兰关节置换项目1998至2019年前瞻性收集的全国性数据,回顾性分析8,301例患者(8,894膝)的翻修全膝关节置换术(RTKA)生存情况。主要结局为十年RTKA生存率,主要解释变量为医院年手术量对RTKA生存的影响。结果显示十年生存率为87.3%(95% CI 86.5至88.1),校正性别、年龄、医生手术量和翻修指征后,高医院手术量与较低的再翻修风险显著相关(HR 0.78,95% CI 0.64至0.94,p<0.001)。
要点
- RTKA十年生存率为87.3%(95% CI 86.5至88.1)。
- 高医院手术量与再翻修风险降低显著相关(HR 0.78,95% CI 0.64至0.94,p<0.001)。
- 年手术量>20例的中心再翻修风险降低16%,>30例降低22%,>40例降低28%。
核心结论
- 苏格兰大多数RTKA生存至十年。
- 医院年手术量超过20例与再翻修风险显著降低独立相关。
- 发展高手术量三级中心可能改善RTKA的总体生存。
研究设计与样本
- 回顾性分析苏格兰关节置换项目数据,该全国性审计前瞻性收集苏格兰所有关节置换手术数据。
- 1998至2019年,8,301例患者(8,894膝)接受RTKA手术,RTKA时中位年龄70岁(IQR 63至76),中位随访6.2年(IQR 3.0至10.2)。
- 4,764例(53.6%)为女性,781例(8.8%)因感染接受治疗。
- 主要结局为RTKA十年生存率,主要解释变量为医院年手术量对RTKA生存的影响。
- 采用Kaplan-Meier生存曲线及多因素Cox比例风险模型估计相对翻修风险,风险比(HR)报告95% CI,p<0.05为统计学显著。
主要发现
- 8,894膝中957膝(10.8%)接受了第二次翻修手术。
- 男性、翻修时较年轻及感染状态阳性与再翻修需求相关。
- RTKA十年生存估计为87.3%(95% CI 86.5至88.1)。
- 校正性别、年龄、医生手术量和翻修指征后,高医院手术量与较低的再翻修风险显著相关(HR 0.78,95% CI 0.64至0.94,p<0.001)。
- 年手术量>20例的中心再翻修风险降低16%,>30例降低22%,>40例降低28%,最高手术量中心风险最低。
关键数值与推荐
- RTKA十年生存率为87.3%(95% CI 86.5至88.1)。
- 高医院手术量 vs 低手术量再翻修风险HR 0.78(95% CI 0.64至0.94,p<0.001)。
- 年手术量>20例风险降低16%,>30例降低22%,>40例降低28%。
临床怎么用
- 对于接受翻修全膝关节置换术的患者,选择年手术量>20例的医院可能降低再翻修风险。
- 发展高手术量三级中心可能改善RTKA的总体生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to measure the effect of hospital case volume on the survival of revision total knee arthroplasty (RTKA). METHODS: This is a retrospective analysis of Scottish Arthroplasty Project data, a nationwide audit which prospectively collects data on all arthroplasty procedures performed in Scotland. The primary outcome was RTKA survival at ten years. The primary explanatory variable was the effect of hospital case volume per year on RTKA survival. Kaplan-Meier survival curves were plotted with 95% confidence intervals (CIs) to determine the lifespan of RTKA. Multivariate Cox proportional hazards were used to estimate relative revision risks over time. Hazard ratios (HRs) were reported with 95% CI, and p-value < 0.05 was considered statistically significant. RESULTS: From 1998 to 2019, 8,301 patients (8,894 knees) underwent RTKA surgery in Scotland (median age at RTKA 70 years (interquartile range (IQR) 63 to 76); median follow-up 6.2 years (IQR 3.0 to 10.2). In all, 4,764 (53.6%) were female, and 781 (8.8%) were treated for infection. Of these 8,894 knees, 957 (10.8%) underwent a second revision procedure. Male sex, younger age at index revision, and positive infection status were associated with need for re-revision. The ten-year survival estimate for RTKA was 87.3% (95% CI 86.5 to 88.1). Adjusting for sex, age, surgeon volume, and indication for revision, high hospital case volume was significantly associated with lower risk of re-revision (HR 0.78 (95% CI 0.64 to 0.94, p < 0.001)). The risk of re-revision steadily declined in centres performing > 20 cases per year; risk reduction was 16% with > 20 cases; 22% with > 30 cases; and 28% with > 40 cases. The lowest level of risk was associated with the highest volume centres. CONCLUSION: The majority of RTKA in Scotland survive up to ten years. Increasing yearly hospital case volume above 20 cases is independently associated with a significant risk reduction of re-revision. Development of high-volume tertiary centres may lead to an improvement in the overall survival of RTKA. Cite this article: Bone Joint J 2021;103-B(4):602-609.
引用
- Yapp LZ, Walmsley PJ, Moran M, et al. The effect of hospital case volume on re-revision following revision total knee arthroplasty. Bone Joint J. 2021. PMID: 33789471. doi:10.1302/0301-620X.103B4.BJJ-2020-1901.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。